PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,965,000 | +152.2% | 109,246 | 0.0% | 0.08% | +114.3% |
| Q1 2020 | $779,000 | -79.8% | 109,246 | -32.5% | 0.04% | -76.0% |
| Q4 2019 | $3,866,000 | +24.9% | 161,899 | +40.2% | 0.15% | +8.1% |
| Q3 2019 | $3,096,000 | -1.1% | 115,448 | 0.0% | 0.14% | +5.5% |
| Q2 2019 | $3,132,000 | -21.8% | 115,448 | 0.0% | 0.13% | -21.5% |
| Q1 2019 | $4,006,000 | +77.7% | 115,448 | 0.0% | 0.16% | +69.8% |
| Q4 2018 | $2,254,000 | -26.7% | 115,448 | 0.0% | 0.10% | -13.5% |
| Q3 2018 | $3,074,000 | -9.5% | 115,448 | +28.3% | 0.11% | -14.0% |
| Q2 2018 | $3,398,000 | +15.6% | 89,978 | 0.0% | 0.13% | +13.2% |
| Q1 2018 | $2,939,000 | – | 89,978 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |